Specific gene expression in type 1 diabetic patients with and without cardiac autonomic neuropathy.

Autor: Gastol J; Department of Metabolic Diseases, University Hospital, Krakow, Poland., Polus A; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland., Biela M; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland., Razny U; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland., Pawlinski L; Department of Metabolic Diseases, University Hospital, Krakow, Poland., Solnica B; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland., Kiec-Wilk B; Department of Metabolic Diseases, University Hospital, Krakow, Poland. mbkiec@gmail.com.; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland. mbkiec@gmail.com.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2020 Mar 27; Vol. 10 (1), pp. 5554. Date of Electronic Publication: 2020 Mar 27.
DOI: 10.1038/s41598-020-62498-7
Abstrakt: We hypothesized that some molecular pathways might interact to initiate the process of nervous tissue destruction, promoting cardiac autonomic neuropathy (CAN) in the course of diabetes type 1 (T1D). The study group consisted of 60 T1D patients (58.33% women/41.67% men), on standard therapy. The control group consisted of twenty healthy volunteers recruited in accordance with age, gender and body weight. The presence of CAN was documented by the Ewing test method (ProSciCard apparatus). A microarray data analysis was performed using Gene Spring version 13. The microarray results for selected genes were confirmed by real-time PCR (qRT-PCR), using specific TaqMan Gene Expression Assays. Plasma IL-6 content was measured by an enzyme-linked immunosorbent assay (ELISA). The p < 0.05 value was considered as statistically significant. The microarray analysis, confirmed by qRTPCR, showed significant up-regulation of autophagy, quantity of mitochondria, quality regulatory genes (mTOR, GABARAPL2) apoptosis, ER-stress and inflammation (NFKB1, IL1b, IL1R1, SOD1), in T1D when compared to the control group. A significantly higher IL-6 protein level was observed in T1D patients, in comparison to the control group. We concluded that the observed changes in gene expression and activation of intracellular pathways give a coherent picture of the important role of oxidative stress in inflammation and the activation of apoptosis in the pathomechanism of DM. The significance of the inflammatory process, confirmed by the increased level of the inflammation biomarker IL-6 in the pathomechanisms of CAN was shown even in patients with properly treated T1D.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje